Proteomic interrogation of antibiotic resistance and persistence in Escherichia coli – progress and potential for medical research

References

• Livermore DM. Discovery research: the scientific challenge of finding new antibiotics. J Antimicrob Chemother. 2011;66:1941–1944.
   PubMed Web of Science ®Google Scholar
• Saga T, Yamaguchi K. History of antimicrobial agents and resistant. Jpn Med Assoc J. 2009;137:103–108.
   Google Scholar
• Abraham EP, Chain E. An enzyme from bacteria able to destroy penicillin. Nature. 1940;146:837.
   Google Scholar
• Rather IA, Kim BC, Bajpai VK, et al. Self-medication and antibiotic resistance: crisis, current challenges, and prevention. Saudi J Biol Sci. 2017;24:808–812.
   PubMed Web of Science ®Google Scholar
• Martens E, Demain AL. The antibiotic resistance crisis, with a focus on the United States. J Antibiot. 2017;70:520–526.
   PubMed Web of Science ®Google Scholar
• Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America. Clin Infect Dis. 2016;62:e51–77.
   PubMed Web of Science ®Google Scholar
• WHO. Antimicrobial resistance: global report on surveillance. 2014; Geneva: World Health Organisation.
   Google Scholar
• Thabit AK, Crandon JL, Nicolau DP. Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials. Expert Opin Pharmacother. 2015;16:159–177.
   PubMed Web of Science ®Google Scholar
• Bigger JW. Treatment of Staphylococcal infections with penicillin. Lancet. 1944;244:497–500.
   Google Scholar
• Jung SH, Ryu CM, Kim JS. Bacterial persistence: fundamentals and clinical importance. J Microbiol. 2019;57:829–835.
   PubMed Web of Science ®Google Scholar
• Zhao J, Schloss PD, Kalikin LM, et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A. 2012;109:5809–5814.
   PubMed Web of Science ®Google Scholar
• Hayden HS, Lim R, Brittnache MJ, et al. Evolution of Burkholderia pseudomallei in recurrent melioidosis. PLoS One. 2012;7:e36507.
   PubMed Web of Science ®Google Scholar
• Windels EM, Michiels JE, Fauvart M, et al. Bacterial persistence promotes the evolution of antibiotic resistance by increasing survival and mutation rates. Isme J. 2019;13:1239–1251.
   PubMed Web of Science ®Google Scholar
• Cohen NR, Lobritz MA, Collins JJ. Microbial persistence and the road to drug resistance. Cell Host Microbe. 2013;13:632–642.
   PubMed Web of Science ®Google Scholar
• Levin‑Reisman I, Ronin I, Gefen O, et al. Antibiotic tolerance facilitates the evolution of resistance. Science. 2017;355:826–830.
   PubMed Web of Science ®Google Scholar
• Poirel L, Madec JY, Lupo A, et al. Antimicrobial resistance in Escherichia coli. Microbiol Spectr. 2018;6:1–27.
   Web of Science ®Google Scholar
• Keren I, Shah D, Spoering A, et al. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol. 2004;186:8172–8180.
   PubMed Web of Science ®Google Scholar
• Shan Y, Gandt AB, Rowe SE, et al. ATP-dependent persister formation in Escherichia coli. mBio. 2017;8:e02267–16.
   PubMed Web of Science ®Google Scholar
• Lee PS, Lee KH. Escherichia coli - a model system that benefits from and contributes to the evolution of proteomics. Biotechnol Bioeng. 2003;84:801–814.
   PubMed Web of Science ®Google Scholar
• O’Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975;250:4007–4021.
   PubMed Web of Science ®Google Scholar
• Pulido M, García-Quintanilla M, Gil-Marqués ML, et al. Identifying targets for antibiotic development using omics technologies. Drug Discov Today. 2016;21:465–472.
   PubMed Web of Science ®Google Scholar
• Marx V. A dream of single-cell proteomics. Nat Methods. 2019;16:809–812.
   PubMed Web of Science ®Google Scholar
• Amani J, Mirhosseini SA, Fooladi AA. A review approaches to identify enteric bacterial pathogens. Jundishapur J Microbiol. 2015;8:e17473.
   PubMed Web of Science ®Google Scholar
• Esfandiari P, Amani J, Fouladi AA, et al. Rapid specific and polymerase chain reaction-enzyme linked immunosorbent assay for detection of Escherichia coli LT toxin from clinical isolates. Arch Clin Infect Dis. 2017;12:e36261.
   Web of Science ®Google Scholar
• Cardona-Arias JA, Orrego-Marin CP, Henao-ejia CP. Prevalencia de infección urinaria, uropatógenos y perfil de susceptibilidad antimicrobiana, medellín 2011-2012. Acta Médica Colombiana. 2014;39:352–358.
   Google Scholar
• Piras C, Soggiu A, Bonizzi L, et al. Comparative proteomics to evaluate multi-drug resistance in Escherichia coli. Mol Biosyst. 2012;8:1060–1067.
   PubMedGoogle Scholar
• Pormohammad A, Nasiri MJ, Azimi T. Prevalence of antibiotic resistance in Escherichia coli strains simultaneously isolated from humans, animals, food, and the environment: a systematic review and meta-analysis. Infect Drug Resist. 2019;12:1181–1197.
   PubMed Web of Science ®Google Scholar
• Jeannot K, Bolard A, Plésiat P. Resistance to polymyxins in gram-negative organisms. Int J Antimicrob Agents. 2017;49:526–535.
   PubMed Web of Science ®Google Scholar
• O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. 2016; https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf
   Google Scholar
• Eiamphungporna W, Yainoya S, Jumderm C, et al. Prevalence of the colistin resistance gene mcr-1 in colistin-resistant isolated from humans in Thailand. J Glob Antimicrob Resistance. 2018;15:32–35.
   PubMed Web of Science ®Google Scholar
• Alegría Á, Arias-Temprano M, Fernández-Natal I, et al. Molecular diversity of ESBL-producing Escherichia coli from foods of animal origin and human patients. Int J Environ Res Public Health. 2020;17:1312.
   Web of Science ®Google Scholar
• Frantzi M, Latosinska A, Mischak H. Proteomics in drug development: the dawn of a new era? Proteomics Clin Appl. 2019;13:e1800087.
   PubMed Web of Science ®Google Scholar
• Gil C, Monteoliva L. Trends in microbial proteomics. J Proteomics. 2014;97:1–2.
   PubMed Web of Science ®Google Scholar
• Vranakis I, Goniotakis I, Psaroulaki A, et al. Proteome studies of bacterial antibiotic resistance mechanisms. J Proteomics. 2014;97:88–99.
   PubMed Web of Science ®Google Scholar
• Park AJ, Krieger JR, Khursigara CM. Survival proteomes: the emerging proteotype of antimicrobial resistance. FEMS Microbiol Rev. 2016;40:323–342.
   PubMed Web of Science ®Google Scholar
• Bąchor R, Waliczek M, Stefanowicz P, et al. Trends in the design of new isobaric labeling reagents for quantitative proteomics. Molecules. 2019;24:701.
   Web of Science ®Google Scholar
• Liu X, Wang JP, Chen M, et al. Comparative proteomic analysis reveals drug resistance of Staphylococcus xylosus ATCC700404 under tylosin stress. BMC Vet Res. 2019;15:224.
   PubMed Web of Science ®Google Scholar
• Su YB, Kuang SF, Peng XX, et al. The depressed P cycle contributes to the acquisition of ampicillin resistance in Edwardsiella piscicida. J Proteomics. 2020;212:103562.
   PubMed Web of Science ®Google Scholar
• Pais P, Costa C, Pires C, et al. Membrane proteome-wide response to the antifungal drug clotrimazole in Candida glabrata: role of the transcription factor CgPdr1 and the drug: H+ antiporters CgTpo1_1 and CgTpo1_2. Mol Cell Proteomics. 2016;15:57–72.
   PubMed Web of Science ®Google Scholar
• Li WX, Yao ZJ, Zhang XY, et al. Global protein expression profile response of planktonic Aeromonas hydrophila exposed to chlortetracycline. World J Microbiol Biotechnol. 2017;33:68.
   PubMed Web of Science ®Google Scholar
• Wang JR, Zhang JL, Fu Q, et al. Proteomic analyses uncover the mechanisms underlying antibiotic resistance differences among three Acinetobacter baumannii isolates. J Mol Microbiol Biotechnol. 2016;26:401–409.
   PubMed Web of Science ®Google Scholar
• Li WX, Wang GB, Zhang S, et al. An integrated quantitative proteomic and metabolomics approach to reveal the negative regulation mechanism of LamB in antibiotics resistance. J Proteomics. 2019;194:148–159.
   PubMed Web of Science ®Google Scholar
• Zhang L, Chen XQ, Song JY, et al. Comparative proteomics analysis of Escherichia coli in response to barofloxacin stress. Biotech Bulletin. 2019;35:103–109.
   Google Scholar
• Li H, Wang YY, Meng QS, et al. Comprehensive proteomic and metabolomic profiling of mcr-1-mediated colistin resistance in Escherichia coli. Int J Antimicrob Agents. 2019;53:795–804.
   PubMed Web of Science ®Google Scholar
• Vidova V, Spaci Z. A review on mass spectrometry-based quantitative proteomics: targeted and data independent acquisition. Anal Chim Acta. 2017;964:7–23.
   PubMed Web of Science ®Google Scholar
• Saleh S, Staes A, Deborggraeve S, et al. Targeted proteomics for studying pathogenic bacteria. Proteomics. 2019;16:e1800435.
   Google Scholar
• Grundt A, Findeisen P, Miethke T, et al. Rapid detection of ampicillin resistance in Escherichia coli by quantitative mass spectrometry. J Clin Microbiol. 2012;50:1727–1729.
   PubMed Web of Science ®Google Scholar
• Haag AM, Medina AM, Royall AE, et al. Monitoring bacterial resistance to chloramphenicol and other antibiotics by liquid chromatography electrospray ionization tandem mass spectrometry using selected reaction monitoring. J Mass Spectrom. 2013;48:732–739.
   PubMed Web of Science ®Google Scholar
• Ke M, Shen HN, Wang LJ, et al. Identification, quantification, and site localization of protein posttranslational modifications via mass spectrometry-based proteomics. Adv Exp Med Biol. 2016;919:345–382.
   PubMed Web of Science ®Google Scholar
• Hennrich ML, Gavin AC. Quantitative mass spectrometry of posttranslational modifications: keys to confidence. Sci Signal. 2015;8:re5.
   PubMed Web of Science ®Google Scholar
• Olsen JV, Mann M. Status of large-scale analysis of posttranslational modifications by mass spectrometry. Mol Cell Proteomics. 2013;12:3444–3452.
   PubMed Web of Science ®Google Scholar
• Mertins P, Qiao JW, Patel J, et al. Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat Methods. 2013;10:634–637.
   PubMed Web of Science ®Google Scholar
• Van der Wal L, Bezstarosti K, Sap KA, et al. Improvement of ubiquitylation site detection by Orbitrap mass spectrometry. J Proteomics. 2018;172:49–56.
   PubMed Web of Science ®Google Scholar
• Cole J, Hanson EJ, James DC, et al. Comparison of data-acquisition methods for the identification and quantification of histone post-translational modifications on a Q exactive HF hybrid quadrupole Orbitrap mass spectrometer. Rapid Commun Mass Spectrom. 2019;33:897–906.
   PubMed Web of Science ®Google Scholar
• Yu Q, Shi XD, Feng Y, et al. Improving data quality and preserving HCD-generated reporter ions with EThcD for isobaric tag-based quantitative proteomics and proteome-wide PTM studies. Anal Chim Acta. 2017;968:40–49.
   PubMed Web of Science ®Google Scholar
• Udeshi ND, Mani DC, Satpathy S, et al. Rapid and deep-scale ubiquitylation profiling for biology and translational research. Nat Commun. 2020;11:359.
   PubMed Web of Science ®Google Scholar
• Storey AJ, Hardman RE, Byrum SD, et al. Accurate and sensitive quantitation of the dynamic heat shock proteome using tandem mass tag. J Proteome Res. 2020;19:1183–1195.
   PubMed Web of Science ®Google Scholar
• Soares NC, Spät P, Méndez JA, et al. Ser/Thr/Tyr phosphoproteome characterization of Acinetobacter baumannii: comparison between a reference strain and a highly invasive multidrug-resistant clinical isolate. J Proteomics. 2014;102:113–124.
   PubMed Web of Science ®Google Scholar
• Xie L, Wang X, Zeng J, et al. Proteome-wide lysine acetylation profling of the human pathogen Mycobacterium tuberculosis. Int J Biochem Cell Biol. 2015;59:193–202.
   PubMed Web of Science ®Google Scholar
• Potel CM, Lin MH, Heck AJR, et al. Widespread bacterial protein histidine phosphorylation revealed by mass spectrometry-based proteomics. Nat Methods. 2018;15:187–190.
   PubMed Web of Science ®Google Scholar
• Potel CM, Lin MH, Heck AJR, et al. Defeating major contaminants in Fe(3+)- immobilized metal ion affinity chromatography (IMAC) phosphopeptide enrichment. Mol Cell Proteomics. 2018;17:1028–1034.
   PubMed Web of Science ®Google Scholar
• Lin MH, Potel CM, Tehrani KHME, et al. New tool to reveal bacterial signaling mechanisms in antibiotic treatment and resistance. Mol Cell Proteomics. 2018;17:2496–2507.
   PubMed Web of Science ®Google Scholar
• Tiwari S, Jamal SB, Hassan SS, et al. Two-component signal transduction systems of pathogenic bacteria as targets for antimicrobial therapy: an overview. Front Microbiol. 2017;8:1878.
   PubMed Web of Science ®Google Scholar
• Frost LS, Koraimann G. Regulation of bacterial conjugation: balancing opportunity with adversity. Future Microbiol. 2010;5:1057–1071.
   PubMed Web of Science ®Google Scholar
• Vega NM, Allison KR, Khalil AS, et al. Signaling-mediated bacterial persister formation. Nat Chem Biol. 2012;8:431–433.
   PubMed Web of Science ®Google Scholar
• Blair JMA, Webber MA, Baylay AJ, et al. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015;13:42–51.
   PubMed Web of Science ®Google Scholar
• Zgurskaya HI, Rybenkov VV, Krishnamoorthy G, et al. Trans-envelope multidrug efflux pumps of Gram-negative bacteria and their synergism with the outer membrane barrier. Res Microbiol. 2018;169:351–356.
   PubMed Web of Science ®Google Scholar
• Zabawa TP, Pucci MJ, Parr TR, et al. Treatment of gram-negative bacterial infections by potentiation of antibiotics. Curr Opin Microbiol. 2016;33:7–12.
   PubMed Web of Science ®Google Scholar
• Zgurskaya HI, Rybenkov VV. Permeability barriers of gram-negative pathogens. Ann NY Acad Sci. 2020;1459:5–18.
   PubMed Web of Science ®Google Scholar
• Peng B, Li H, Peng XX. Proteomics approach to understand bacterial antibiotic resistance strategies. Expert Rev Proteomics. 2019;16:829–839.
   PubMed Web of Science ®Google Scholar
• Li WX, Zhang S, Wang XY, et al. Systematically integrated metabonomic-proteomic studies of Escherichia coli under ciprofloxacin stress. J Proteomics. 2018;179:61–70.
   PubMed Web of Science ®Google Scholar
• Lin XM, Yang MJ, Li H, et al. Decreased expression of LamB and Odp1 complex is crucial for antibiotic resistance in Escherichia coli. J Proteome. 2014;98:244–253.
   PubMed Web of Science ®Google Scholar
• Qi J, Du YJ, Bai H, et al. Global protein expression profile response of Escherichia coli ATCC 25922 exposed to enrofloxacin. Microb Drug Resisr. 2013;19:6–14.
   PubMed Web of Science ®Google Scholar
• Kalule JB, Fortuin S, Calder B, et al. Proteomic comparison of three clinical diarrhoeagenic drug-resistant Escherichia coli isolates grown on CHROMagar™STEC media. J Proteomics. 2018;180:25–35.
   PubMed Web of Science ®Google Scholar
• Li H, Lin XM, Wang SY, et al. Identification and antibody-therapeutic targeting of chloramphenicol-resistant outer membrane proteins in Escherichia coli. J Proteome Res. 2007;6:3628–3636.
   PubMed Web of Science ®Google Scholar
• Ramos S, Silva N, Hébraud M, et al. Proteomics for drug resistance on the food chain? Multidrug-resistant Escherichia coli proteomes from slaughtered pigs. OMICS. 2016;20:362–374.
   PubMed Web of Science ®Google Scholar
• Jin M, Lu J, Chen ZY, et al. Antidepressant fluoxetine induces multiple antibiotics resistance in Escherichia coli via ROS-mediated mutagenesis. Environ Int. 2018;120:421–430.
   PubMed Web of Science ®Google Scholar
• Pinto L, Torres C, Gil C, et al. Multiomics assessment of gene expression in a clinical strain of CTX-M-15-producing ST131 Escherichia coli. Front Microbiol. 2019;10:831.
   PubMed Web of Science ®Google Scholar
• Kumar D, Bansal G, Narang A, et al. Integrating transcriptome and proteome profiling: strategies and applications. Proteomics. 2016;16:2533–2544.
   PubMed Web of Science ®Google Scholar
• Fernández L, Hancock RE. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev. 2012;25:661–681.
   PubMed Web of Science ®Google Scholar
• Hart EM, Mitchell AM, Konovalova A, et al. A small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier. Proc Natl Acad Sci U S A. 2019;116:21748–21757.
   PubMed Web of Science ®Google Scholar
• Zabawa TP, Pucci MJ, Parr TR Jr, et al. Treatment of gram-negative bacterial infections by potentiation of antibiotics. Curr Opin Microbiol. 2016;33:7–12.
   PubMed Web of Science ®Google Scholar
• Lin L, Nonejuie P, Munguia J, et al. Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant gram-negative bacterial pathogens. EBioMedicine. 2015;2:690–698.
   PubMed Web of Science ®Google Scholar
• Mohamed YF, Abou-Shleib HM, Khalil AM, et al. Membrane permeabilization of colistin toward pan-drug resistant gram-negative isolates. Braz J Microbiol. 2016;47:381–388.
   PubMed Web of Science ®Google Scholar
• Ofek I, Cohen S, Rahmani R, et al. Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice. Antimicrob Agents Chemother. 1994;38:374–377.
   PubMed Web of Science ®Google Scholar
• Vaara M, Siikanen O, Apajalahti J, et al. A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane. Antimicrob Agents Chemother. 2010;54:3341–3346.
   PubMed Web of Science ®Google Scholar
• Corbett D, Wise A, Langley T, et al. Potentiation of antibiotic activity by a novel cationic peptide: potency and spectrum of activity of SPR741. Antimicrob Agents Chemother. 2017;61:e00200–17.
   PubMed Web of Science ®Google Scholar
• Goldberg K, Sarig H, Zaknoon F, et al. Sensitization of gram-negative bacteria by targeting the membrane potential. Faseb J. 2013;27:3818–3826.
   PubMed Web of Science ®Google Scholar
• Livne L, Epand RF, Papahadjopoulos-Sternberg B, et al. OAK-based cochleates as a novel approach to overcome multidrug resistance in bacteria. Faseb J. 2010;24:5092–5101.
   PubMed Web of Science ®Google Scholar
• Jammal J, Zaknoon F, Kaneti G, et al. Sensitization of gram-negative bacteria to rifampin and OAK combinations. Sci Rep. 2015;5:9216.
   PubMed Web of Science ®Google Scholar
• Opperman TJ, Nguyen ST. Recent advances toward a molecular mechanism of efflux pump inhibition. Front Microbiol. 2015;6:421.
   PubMed Web of Science ®Google Scholar
• Eicher T, Cha HJ, Seeger MA, et al. Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop. Proc Natl Acad Sci USA. 2012;109:5687–5692.
   PubMed Web of Science ®Google Scholar
• Abdel-Halim H, Al Dajani A, Abdelhalim A, et al. The search of potential inhibitors of the AcrAB–TolC system of multidrug-resistant Escherichia coli: an in silico approach. Appl Microbiol Biotechnol. 2019;103:6309–6318.
   PubMed Web of Science ®Google Scholar
• Reza A, Sutton JM, Rahman KM. Effectiveness of efflux pump inhibitors as biofilm disruptors and resistance breakers in gram-negative (ESKAPEE) bacteria. Antibiotics (Basel). 2019;8:229.
   Web of Science ®Google Scholar
• Misra R, Morrison KD, Cho HJ, et al. Importance of real-time assays to distinguish multidrug efflux pump-inhibiting and outer membrane-destabilizing activities in Escherichia coli. J Bacteriol. 2015;197:2479–2488.
   PubMed Web of Science ®Google Scholar
• Wang YH, Mowla R, Ji SL, et al. Design, synthesis and biological activity evaluation of novel 4-subtituted 2-naphthamide derivatives as AcrB inhibitors. Eur J Med Chem. 2018;143:699–709.
   PubMed Web of Science ®Google Scholar
• Sjuts H, Vargiu AV, Kwasny SM, et al. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives. Proc Natl Acad Sci U S A. 2016;113:3509–3514.
   PubMed Web of Science ®Google Scholar
• Hegarty JP, Stewart DB Sr. Advances in therapeutic bacterial antisense biotechnology. Appl Microbiol Biotechnol. 2018;102:1055–1065.
   PubMed Web of Science ®Google Scholar
• Greenberg DE, Marshall-Batty KR, Brinster LR, et al. Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex. J Infect Dis. 2010;201:1822–1830.
   PubMed Web of Science ®Google Scholar
• Parker A, Gottesman S. Small RNA regulation of tolC, the outer membrane component of bacterial multidrug transporters. J Bacteriol. 2016;198:1101–1113.
   PubMed Web of Science ®Google Scholar
• Choi JS, Kim W, Suk S, et al. The small RNA, SdsR, acts as a novel type of toxin in Escherichia coli. RNA Biol. 2018;15:1319–1335.
   PubMed Web of Science ®Google Scholar
• Ayhan DH, Tamer YT, Akbar M, et al. Sequence-specific targeting of bacterial resistance genes increases antibiotic efficacy. PLoS Biol. 2016;14:e1002552.
   PubMed Web of Science ®Google Scholar
• Ayaz M, Subhan F, Sadiq A, et al. Cellular efflux transporters and the potential role of natural products in combating efflux mediated drug resistance. Front Biosci (Landmark ED). 2017;22:732–756.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75:311–335.
   PubMed Web of Science ®Google Scholar
• Kumar V, Shriram V, Mulla J. Antibiotic resistance reversal of multiple drug resistant bacteria using Piper longum fruit extract. J Appl Pharm Sci. 2013;3:112–116.
   Google Scholar
• Prasch S, Bucar F. Plant derived inhibitors of bacterial efflux pumps: an update. Phytochem Rev. 2015;14:961.
   Web of Science ®Google Scholar
• Hwang D, Lim YH. Resveratrol controls Escherichia coli growth by inhibiting the AcrAB-TolC efflux pump. FEMS Microbiol Lett. 2019;366:fnz030.
   PubMed Web of Science ®Google Scholar
• Wei SM, Yang YF, Tian W, et al. Synergistic activity of fluoroquinolones combining with artesunate against multidrug-resistant Escherichia coli. Microb Drug Resist. 2020;26:81–88.
   PubMed Web of Science ®Google Scholar
• Zhou XZ, Jia F, Liu XM, et al. Total alkaloids of Sophorea alopecuroides induced down-regulation of AcrAB-TolC efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant Escherichia coli isolates. Phytother Res. 2012;26:1637–1643.
   PubMed Web of Science ®Google Scholar
• Ohene-Agyei T, Mowla R, Rahman T, et al. Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump. MicrobiologyOpen. 2014;3:885–896.
   PubMed Web of Science ®Google Scholar
• Wang YH, Alenzy R, Song D, et al. Structural optimization of natural product nordihydroguaretic acid to discover novel analogues as AcrB inhibitors. Eur J Med Chem. 2020;186:111910.
   Google Scholar
• Helaine S, Kugelberg E. Bacterial persisters: formation, eradication, and experimental systems. Trends Microbiol. 2014;22:417–424.
   PubMed Web of Science ®Google Scholar
• Harms A, Maisonneuve E, Gerdes K. Mechanisms of bacterial persistence during stress and antibiotic exposure. Science. 2016;354:aaf4268.
   PubMed Web of Science ®Google Scholar
• Michiels JE, Van den Bergh B, Verstraeten N, et al. Molecular mechanisms and clinical implications of bacterial persistence. Drug Resist Updat. 2016;29:76–89.
   PubMed Web of Science ®Google Scholar
• Kaldalu N, Hauryliuk V, Tenson T. Persisters - as elusive as ever. Appl Microbiol Biotechnol. 2016;100:6545–6553.
   PubMed Web of Science ®Google Scholar
• Lippolis JD, Holman DB, Brunelle BW, et al. Genomic and transcriptomic analysis of Escherichia coli strains associated with persistent and transient bovine mastitis and the role of colanic acid. Infect Immun. 2017;86:e00566–17.
   PubMed Web of Science ®Google Scholar
• Hu Y, Coates AR. Transposon mutagenesis identifies genes which control antimicrobial drug tolerance in stationary-phase Escherichia coli. FEMS Microbiol Lett. 2005;243:117–124.
   PubMed Web of Science ®Google Scholar
• Lewis K. Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol. 2008;322:107–131.
   PubMed Web of Science ®Google Scholar
• Sulaiman JE, Hao C, Lam H. Specific enrichment and proteomics analysis of Escherichia coli persisters from rifampin pretreatment. J Proteome Res. 2018;17:3984–3996.
   PubMed Web of Science ®Google Scholar
• Windels EM, Meriem ZB, Zahir T, et al. Enrichment of persisters enabled by a β-lactam-induced filamentation method reveals their stochastic single-cell awakening. Commun Biol. 2019;2:426.
   PubMed Web of Science ®Google Scholar
• Shah D, Zhang ZG, Khodursky A, et al. Persisters: a distinct physiological state of E. coli. BMC Microbiol. 2006;6:53.
   PubMed Web of Science ®Google Scholar
• Johnson PJT, Levin BR. Pharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureus. PLoS Genet. 2013;9:e1003123.
   PubMed Web of Science ®Google Scholar
• Kwan BW, Valenta JA, Benedik MJ, et al. Arrested protein synthesis increases persister-like cell formation. Antimicrob Agents Chemother. 2013;57:1468–1473.
   PubMed Web of Science ®Google Scholar
• Cañas-Duarte SJ, Restrepo S, Pedraza JM. Novel protocol for persister cells isolation. Plos One. 2014;9:e88660.
   PubMed Web of Science ®Google Scholar
• Radzikowski JL, Vedelaar S, Siegel D, et al. Bacterial persistence is an active σS stress pesponse to metabolic flux limitation. Mol Syst Biol. 2016;12:882.
   PubMed Web of Science ®Google Scholar
• Fridman O, Goldberg A, Ronin I, et al. Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations. Nature. 2014;513:418–421.
   PubMed Web of Science ®Google Scholar
• Van den Bergh B, Michiels JE, Wenseleers T, et al. Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence. Nat Microbiol. 2016;1:16020.
   PubMed Web of Science ®Google Scholar
• Sulaiman JE, Lam H. Proteomic investigation of tolerant Escherichia coli populations from cyclic antibiotic treatment. J Proteome Res. 2020;19:900–913.
   PubMed Web of Science ®Google Scholar
• Norton JP, Mulvey MA. Toxin-antitoxin systems are important for niche-specific colonization and stress resistance of uropathogenic Escherichia coli. PLoS Pathog. 2012;8:e1002954.
   PubMed Web of Science ®Google Scholar
• Maisonneuve E, Gerdes K. Molecular mechanisms underlying bacterial persisters. Cell. 2014;157:539–548.
   PubMed Web of Science ®Google Scholar
• Schumacher MA, Balani P, Min J, et al. HipBA-promoter structures reveal the basis of heritable multidrug tolerance. Nature. 2015;524:59–64.
   PubMed Web of Science ®Google Scholar
• Fernández-García L, Blasco L, Lopez M, et al. Toxin-antitoxin systems in clinical pathogens. Toxins(basel). 2016;8:227.
   Web of Science ®Google Scholar
• Korch SB, Hill TM. Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J Bacteriol. 2006;188:3826–3836.
   PubMed Web of Science ®Google Scholar
• Maisonneuve E, Shakespeare LJ, Jørgensen MG, et al. Bacterial persistence by RNA endonucleases. Proc Natl Acad Sci U S A. 2011;108:13206–13211.
   PubMed Web of Science ®Google Scholar
• Li TG, Yin N, Liu HB, et al. Novel inhibitors of toxin HipA reduce multidrug tolerant persisters. ACS Med Chem Lett. 2016;7:449–453.
   PubMed Web of Science ®Google Scholar
• Bokinsky G, Baidoo EEK, Akella S, et al. HipA-triggered growth arrest and beta-lactam tolerance in Escherichia coli are mediated by RelA-dependent p(ppGpp) synthesis. J Bacteriol. 2013;195:3173–3182.
   PubMed Web of Science ®Google Scholar
• Verstraeten N, Knapen WJ, Kint CL, et al. Obg and membrane depolarization are part of a microbial bet-hedging strategy that leads to antibiotic tolerance. Mol Cell. 2015;59:9–21.
   PubMed Web of Science ®Google Scholar
• Svenningsen MS, Veress A, Harms A, et al. Birth and resuscitation of (p)ppGpp induced antibiotic tolerant persister cells. Sci Rep. 2019;9:6056.
   PubMed Web of Science ®Google Scholar
• Wexselblatt E, Katzhendler J, Saleem-Batcha R, et al. ppGpp analogues inhibit synthetase activity of rel proteins from gram-negative and gram-positive bacteria. Bioorg Med Chem. 2010;18:4485–4497.
   PubMed Web of Science ®Google Scholar
• Dahl JU, Gray MJ, Bazopoulou D, et al. The antiinflammatory drug mesalamine targets bacterial polyphosphate accumulation. Nat Microbiol. 2017;2:16267.
   PubMed Web of Science ®Google Scholar
• Usui M, Yokoo H, Tamura Y, et al. Zinc acetate potentiates the action of tosufloxacin against Escherichia coli biofilm persisters. Antimicrob Agents Chemother. 2019;63:19.
   Web of Science ®Google Scholar
• Lee JH, Kim YG, Kim CJ, et al. Indole-3-acetaldehyde from rhodococcus sp. BFI 332 inhibits Escherichia coli O157: H7biofilm formation. Appl Microbiol Biotechnol. 2012;96:1071–1078.
   PubMed Web of Science ®Google Scholar
• Pu YY, Zhao ZL, Li YX, et al. Enhanced efflux activity facilitates drug tolerance in dormant bacterial cells. Mol Cell. 2016;62:284–294.
   PubMed Web of Science ®Google Scholar
• Varga ZG, Armada A, Cerca P, et al. Inhibition of quorum sensing and efflux pump system by trifluoromethyl ketone proton pump inhibitors. In vivo. 2012;26:277–285.
   Google Scholar
• Tsai CF, Zhao R, Williams SM, et al. An improved boosting to amplify signal with isobaric labeling (iBASIL) strategy for precise quantitative single-cell proteomics. Mol Cell Proteomics. 2020;19:828–838.
   PubMed Web of Science ®Google Scholar